Cholecystitis, Acute Clinical Trial
— CholeRiskScoreOfficial title:
How to Predict Postoperative Complications After Early Laparoscopic Cholecystectomy for Acute Cholecystitis: the Chole-Risk Score
Acute calculous cholecystitis (ACC) is the most common complication of gallstone disease, and laparoscopic cholecystectomy is the gold standard treatment. Several prospective studies have demonstrated that same-admission, early LC (ELC), for ACC is safe when compared with delayed LC (DLC). However, there is still controversy on the indication of ELC in high risk patients with important comorbidities, in cases of severe inflammation of the gallbladder and in patients with ACC and suspicious of a choledocholithiasis. The advantages of ELC in high risk patients with severe comorbidities have been recently questioned, with Tokyo Guidelines 2018 (TG18) proposing an initial conservative management of this cases, assessing the benefit of ELC according to specified criteria. However, the recent CHOCOLATE trial, demonstrated the advantages of ELC over an initial conservative management. Performing an ELC for ACC can be a straightforward procedure for an on-call general surgeon or a very challenging procedure even for experienced hepatopancreaticobiliary (HPB) laparoscopic surgeon, depending on disease features, surgeons experience, centres volumes and resources available. Deciding whether the ELC should be performed by the on-call team or by HPB surgical team, or whether the operation should be delayed are still matter of debate in daily practice. Several preoperative scores assessing the risk of difficult cholecystectomy have been proposed, but they were mainly focused on elective procedures and on risk of conversion to open cholecystectomy or other intraoperative complications. They did not asses the risk of post-operative complications in a subgroup of patients, for whom, indication to ELC by the on-call general surgeon is still questionable according to the more recent guidelines.
Status | Completed |
Enrollment | 1868 |
Est. completion date | September 30, 2020 |
Est. primary completion date | July 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients aged 18 years or older diagnosed with Acute calculous cholecystitis. - Consecutive patients undergoing early laparoscopic cholecystectomy between January 2013 and December 2018 during admission for the acute episode. - Minimum 30-day post-operative follow-up. - ASA = 3. Exclusion Criteria: - Presence of another concomitant pathology of the bile duct (choledocholithiasis, cholangitis, pancreatitis, biliary peritonitis). - Aetiology other than cholelithiasis (amythiasis, malignancy). - Patients with severe sepsis, immunosuppression and pregnancy. - Additional abdominal surgical procedure. - ASA 4. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Universitario Príncipe de Asturias | Alcalá De Henares | Madrid |
Spain | Hospital Universitario German Trias I Pujol | Badalona | Barcelona |
Spain | Hospital Universitario Cruces | Bilbao | Vizcaya |
Spain | Hospital de Cabueñes | Gijón | Asturias |
Spain | Hospital General Universitario Gregorio Marañón | Madrid | |
Spain | Hospital Universitario de la Princesa | Madrid | |
Spain | Hospital Universitario La Paz | Madrid | |
Spain | Hospital Universitario Ramón y Cajal | Madrid | |
Spain | Complejo Asistencial Universitario Salamanca | Salamanca | |
Spain | Hospital Universitario Marqués de Valdecilla | Santander | Cantabria |
Spain | Hospital Universitario Virgen del Rocío | Sevilla |
Lead Sponsor | Collaborator |
---|---|
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Marcello Di Martino |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Increased post-operative complications | Patients who only developed Clavien-Dindo I-II complications were assigned to group 1 (G1), whereas groups 2 (G2) included patients with post-operative complications = IIIa. Patients with post-operative LOS greater than 10 days and who required readmissions within 30 days from the discharge were also assigned to G2. | For at least 30 postoperative days | |
Primary | Number of Participants with Postoperative hemorrhagia | Postoperative hemorrhagia | For at least 30 postoperative days | |
Primary | Number of Participants with Biliary fistula | Biliary fistula | For at least 30 postoperative days | |
Primary | Number of Participants with Jaundice | Jaundice | For at least 30 postoperative days | |
Primary | Number of Participants with Cardiac insufficiency | Cardiac insufficiency | For at least 30 postoperative days | |
Primary | Number of Participants with Heart infarction | Heart infarction | For at least 30 postoperative days | |
Primary | Number of Participants with Respiratory insufficiency | Respiratory insufficiency | For at least 30 postoperative days | |
Primary | Number of Participants with Pulmonary thromboembolism | Pulmonary thromboembolism | For at least 30 postoperative days | |
Primary | Number of Participants with Kidney failure or dialysis | Kidney failure or dialysis | For at least 30 postoperative days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03767881 -
AXIOS™ for Gallbladder Drainage as an Alternative to Percutaneous Drainage IDE
|
N/A | |
Recruiting |
NCT05975385 -
Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
|
N/A | |
Completed |
NCT03470220 -
The Role of Ultrasound in Cholecystitis
|
||
Recruiting |
NCT02972944 -
Laparoscopic Cholecystectomy or Conservative Treatment in the Acute Cholecystitis of Elderly Patients
|
N/A | |
Recruiting |
NCT05702775 -
Endosonography-guided Gallbladder Drainage vs Non-endoscopic Treatment in Inoperable Acute Cholecystitis
|
N/A | |
Recruiting |
NCT04542512 -
Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.
|
||
Recruiting |
NCT04103762 -
Interest of Intravenous Cholangiography With Indocyanine Green in the Context of Laparoscopic Cholecystectomy for Grade 1 and 2 Acute Gallstone Cholecystitis
|
N/A | |
Completed |
NCT03014817 -
Ultrasonically Activated Scalpel Versus Electrocautery Based Dissection in Acute Cholecystitis Trial
|
N/A | |
Active, not recruiting |
NCT04612413 -
A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
|
Phase 2 | |
Withdrawn |
NCT04167072 -
Observation vs Early Removal of LAMS in EUS Guided Cholecystoenterostomy
|
N/A | |
Completed |
NCT04874103 -
Hong Kong Follow up Protocol After EUS Gallbladder Drainage for Acute Cholecistitis
|
||
Completed |
NCT05041686 -
Usefulness of the CADISS® System for the Cleavage of Severe Adhesions in Cholecystectomy
|
N/A | |
Not yet recruiting |
NCT05339282 -
Effectiveness of Empirical Antibiotic Use in Mild to Moderate Acute Inflammatory Gallbladder Disease
|
N/A | |
Recruiting |
NCT06330688 -
Prospective Evaluation of Ultrasound-guided Percutaneous Cholecystostomy With the Trocar Technique
|
||
Completed |
NCT02619149 -
Piperacllin Versus Placebo in Patients Undergoing Surgery for Acute Cholecystitis
|
Phase 3 | |
Not yet recruiting |
NCT04661371 -
Necessity of Preoperative Empirical Antibiotic Use in Acute Cholecystitis
|
N/A | |
Completed |
NCT03050242 -
Benefits of Glycopyrrolate on Intubation With Rigid-videostylet (OptiScope®)
|
N/A | |
Completed |
NCT06178848 -
EEG Parameters Between Remimazolam- and Propofol-based Anesthesia
|
N/A | |
Completed |
NCT02394327 -
Endoscopic Nasogallbladder Drainage Versus Gallbladder Stenting Before Cholecystecomy
|
N/A | |
Completed |
NCT05179629 -
M-Tapa Block for Laparoscopic Cholesistectomy
|
N/A |